Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis

OBJECTIVE: Anti-programmed cell death-1 and programmed cell death ligand-1 (PD-1/PD-L1) inhibitors have been proved to have a significant clinical efficacy in the treatment of non-small cell lung cancer (NSCLC). Many studies have demonstrated that immune-related adverse events (irAEs) are significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Wang, Wei, Yuan, Qi, Li, Li, Wang, Yu-Chao, Chi, Chuan-Zhen, Xu, Chun-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739162/
https://www.ncbi.nlm.nih.gov/pubmed/34821962
http://dx.doi.org/10.1007/s00280-021-04375-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739162/
https://www.ncbi.nlm.nih.gov/pubmed/34821962
http://dx.doi.org/10.1007/s00280-021-04375-2

Ejemplares similares